← brief for 2026-08-17 · Slowing decline

Too sweet to be true? Prophylactic SGLT2 inhibitors before cardiac surgery — NephJC

Page No results yet Not peer reviewed

Key takeaways

This is an online journal club post discussing a new trial. The trial tested dapagliflozin, an SGLT2 drug, to prevent sudden kidney injury after heart surgery. The post is a discussion, not the trial results themselves, so there are no findings to report here.

Source

Page · Forager · 2026-08-17
https://www.nephjc.com/news/2026/8/18/mercuri2